Intercept Pharmaceuticals (ICPT)

[cooler]

Intercept Pharma's Ocaliva Gets FDA Accelerated Approval For Patients With PBC
May 28, 2016, 12:02:00 AM EDT By RTT News

Read more: http://www.nasdaq.com/article/intercept-pharmas-ocaliva-gets-fda-accelerated-approval-for-patients-with-pbc-20160528-00001#ixzz49yOjKFVs

(RTTNews.com) - Intercept Pharmaceuticals, Inc. (ICPT), a biopharmaceutical company focused on non-viral, progressive liver diseases, announced late Friday that the U.S. Food and Drug Administration or FDA has granted accelerated approval to Ocaliva (obeticholic acid) for the treatment of primary biliary cholangitis or PBC.

The company noted that Ocaliva is the first new medicine for PBC in nearly 20 years.


cooler